Last reviewed · How we verify
Single dose of Pentamidine
At a glance
| Generic name | Single dose of Pentamidine |
|---|---|
| Also known as | Pentamidine (7mg/kg) in a single application. |
| Sponsor | Fundação de Medicina Tropical Dr. Heitor Vieira Dourado |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Hypertrophic Scar Prevention by Novel Topical Gel Application (PHASE1, PHASE2)
- Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. (PHASE3)
- Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis (PHASE2)
- A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment (PHASE1, PHASE2)
- A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: